Description
Risperidone-d4, a deuterium-labeled version of Risperidone, acts as a potent antagonist of the dopamine D2 and serotonin 5-HT2 receptors, and inhibits P-Glycoprotein, displaying Ki values of 5.9 nM and 4.8 nM for the dopamine D2 and 5-HT2A receptors, respectively.